Objective The goal of this study was to review the current human papillomavirus (HPV)
vaccine program and its outcomes to date in Australia. Methods This was a review of the …

Background: Australia has included quadrivalent human papillomavirus (HPV) vaccination
in its national program since 2007. Significant declines have been observed in the incidence …

In 2016, the tenth year of quadrivalent human papillomavirus (HPV) vaccine delivery in
Australia by the national immunisation program, it is encouraging to report recent increases …

The size and scope of the impacts of HPV vaccines to date are somewhat extraordinary,
given their apparent limitations and the public health challenges faced at the outset in …

Australia commenced an ongoing school based government funded human
papillomaviruses (HPV)(cervical cancer prevention) vaccination program in April 2007 for …

We are now in the fortunate position of having two highly promising human papillomavirus
(HPV) vaccines in the pipeline. Amidst the excitement of anticipating what these vaccines …

Objective: To describe quadrivalent human papillomavirus (HPV) vaccination coverage
achieved in the HPV vaccination catch‐up program for girls aged 12–17 years. Design …

Human papillomavirus vaccines have been in use in populations for nearly 10 years. They
now have an established record of high efficacy, effectiveness and safety in the prevention …

Abstract▴ Human papillomavirus (HPV) quadrivalent recombinant vaccine is a mixture of
virus-like particles derived from the L1 capsid proteins of HPV types 6, 11, 16 and 18. It is …

Background Cervical cancer occurrence and mortality are strongly correlated with
socioeconomic disadvantage, largely due to unequal access to screening and treatment …